Gaya Herald

Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

 Breaking News
  • No posts were found

Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

March 15
12:51 2022
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Postoperative Pain pipeline insights
DelveInsight’s, “Postoperative Pain – Pipeline Insight, 2022,” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Postoperative Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight’s “Postoperative Pain Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Postoperative Pain pipeline landscapes. 

The report comprises Postoperative Pain pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Postoperative Pain therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Postoperative Pain pipeline products.     

Postoperative Pain Overview

Postoperative pain is a normal response to surgical intervention and is a cause of delayed recovery and discharge after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finances. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.

Some of the key takeaways from the Postoperative Pain Pipeline Report:

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Vivozon, Avenue Therapeutics, Taiwan Liposome Company, etc., are developing therapies for the treatment of Postoperative Pain.
  • Emerging therapies such as VVZ-149 Injections, IV Tramadol, TLC590 (ropivacaine with sustained-release delivery technology), are expected to have a significant impact on the  Postoperative Pain market in the coming years.

Get an overview of pipeline landscape @ Postoperative Pain Clinical Trials Analysis 

Postoperative Pain Pipeline Therapies along with Key Players:

  • VVZ-149 Injections: Vivozon
  • IV Tramadol: Avenue Therapeutics
  • TLC590 (ropivacaine with sustained-release delivery technology): Taiwan Liposome Company

Scope of Postoperative Pain Pipeline Drug Insight    

  • Coverage: Global 
  • Major Players:  Vivozon, Avenue Therapeutics, Taiwan Liposome Company, and others.
  • Pipeline Therapies: VVZ-149 Injections, IV Tramadol, TLC590 (ropivacaine with sustained-release delivery technology), and others.

Table of Contents

1

Postoperative Pain Report Introduction

2

Postoperative Pain Executive Summary

3

Postoperative Pain Overview

4

Postoperative Pain- Analytical Perspective In-depth Commercial Assessment

5

Postoperative Pain Pipeline Therapeutics

6

Postoperative Pain Late Stage Products (Phase II/III)

7

Postoperative Pain Mid Stage Products (Phase II)

8

Postoperative Pain Early Stage Products (Phase I)

9

Postoperative Pain Preclinical Stage Products

10

Postoperative Pain Therapeutics Assessment

11

Postoperative Pain Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Postoperative Pain Key Companies

14

Postoperative Pain Key Products

15

Postoperative Pain Unmet Needs

16 

Postoperative Pain Market Drivers and Barriers

17

Postoperative Pain Future Perspectives and Conclusion

18

Postoperative Pain Analyst Views

19

Appendix

20

About DelveInsight

Related Reports:

Postoperative Pain Market

DelveInsight’s ‘Postoperative Pain-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

Postoperative Pain Epidemiology

DelveInsight’s ‘Postoperative Pain Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Recent Posts

StarCard Sports Games soccer NFT collection sells out again in minutes on the ARC NFT Marketplace

Read Full Article

Categories